Filter Results:
(4,672)
Show Results For
- All HBS Web
(4,672)
- People (16)
- News (1,856)
- Research (2,242)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,821)
Show Results For
- All HBS Web
(4,672)
- People (16)
- News (1,856)
- Research (2,242)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,821)
- 02 Feb 2018
- News
ACHE Announces Regina E. Herzlinger as Honorary Fellow
- 28 Nov 2017
- News
The no-excuses way to manage healthcare growth
- 25 Sep 2017
- News
When a Drug Coupon Helps You but Hurts Fellow Citizens
- 24 Jul 2017
- News
The Company Behind Many Surprise Emergency Room Bills
- 11 Apr 2017
- News
Some Strategies to Limit Sugary Drinks May Backfire
- 11 Apr 2017
- News
5 points on improving physician compliance to hand hygiene practices
- 13 Oct 2016
- News
Study shows coupons lead to big profits for drugmakers
- 01 Dec 2003
- News
HIV/AIDS and Business
incorporates human rights, development, and health issues — it’s the ultimate strategic challenge.” At the Kennedy School workshop, participants discussed a case coauthored by Barrett and Ballou-Aares on Heineken’s efforts to implement an... View Details
- February 2008
- Teaching Note
DermaCare: Zapping Zits Directly (TN)
Teaching Note for [808064]. View Details
- April 2008
- Case
Ophthalmic Consultants of Boston and Dr. Bradford J. Shingleton (2004)
By: H. Kent Bowen and Marcelo Pancotto
Dr. Bradford Shingleton has developed some of the highest quality eye surgery techniques in the industry. He involves his nurses and technicians in creating a surgical service that is constantly improving. The case has many details about how Dr. Shingleton works with... View Details
Keywords: Health Care and Treatment; Independent Innovation and Invention; Service Operations; Performance Productivity; Practice; Problems and Challenges; Health Industry; Boston
Bowen, H. Kent, and Marcelo Pancotto. "Ophthalmic Consultants of Boston and Dr. Bradford J. Shingleton (2004)." Harvard Business School Case 608-151, April 2008.
- 15 Nov 2016
- News
Enabling the Dream of Building A Healthy Future for India
Surabhi Bhandari (photo by Susan Young) Surabhi Bhandari (photo by Susan Young) Surabhi Bhandari (MBA 2017) wants to launch a medical technology startup in India that will help revolutionize health care in... View Details
- 2011
- Working Paper
Individual Rationality and Participation in Large Scale, Multi-Hospital Kidney Exchange
By: Itai Ashlagi and Alvin E. Roth
As multi-hospital kidney exchange clearinghouses have grown, the set of players has grown from patients and surgeons to include hospitals. Hospitals have the option of enrolling only their hard-to-match patient-donor pairs, while conducting easily arranged exchanges... View Details
Keywords: Health Care and Treatment; Resource Allocation; Market Participation; Marketplace Matching; Organizations; Networks; Motivation and Incentives; Health Industry
Ashlagi, Itai, and Alvin E. Roth. "Individual Rationality and Participation in Large Scale, Multi-Hospital Kidney Exchange." NBER Working Paper Series, No. 16720, January 2011.
- September 2002 (Revised April 2006)
- Case
Istituto Clinico Humanitas (A)
By: Richard M.J. Bohmer, Gary P. Pisano and Ning Tang
Istituto Clinico Humanitas is a newly built private hospital, south of Milan, Italy, that has attained unusual profitability while treating public system patients. The hospital was built and is managed by Techosp, a subsidiary of Techint, a global engineering and... View Details
Keywords: Health Care and Treatment; Management Analysis, Tools, and Techniques; Management Systems; Infrastructure; Managerial Roles; Integration; Performance; Health Industry; Milan
Bohmer, Richard M.J., Gary P. Pisano, and Ning Tang. "Istituto Clinico Humanitas (A)." Harvard Business School Case 603-063, September 2002. (Revised April 2006.)
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
accounting that includes health care costs puts the savings figure closer to $1.3 trillion. And capacity to produce an additional 1 billion vaccine courses could similarly be worth on the order of $1... View Details
- November 2012
- Supplement
Amylin Pharmaceuticals (B)
By: Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical... View Details
Keywords: Pharmaceuticals; Bristol-Myers Squibb; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Carin-Isabel Knoop. "Amylin Pharmaceuticals (B)." Harvard Business School Supplement 813-091, November 2012.
- Simulation
Going to the Dentist: Futuredontics
By: Gerald Zaltman
Keywords: Health Care and Treatment
- 01 Dec 2000
- News
Bottom-Line Beauty
cheap. If a product doesn't affect the customer, we don't care about it." Meanwhile, Bluemercury is reaping the benefits of Malcolm's thrift and savvy, with projected revenues of $8 million for 2000 and five new stores slated to open in... View Details
- 02 Jul 2019
- Working Paper Summaries
Risk-Mitigating Technologies: The Case of Radiation Diagnostic Devices
- July 2001 (Revised March 2020)
- Case
Medtronic: Patient Management Initiative (A)
By: Regina E. Herzlinger and Mark P. Allyn
Herzlinger, Regina E., and Mark P. Allyn. "Medtronic: Patient Management Initiative (A)." Harvard Business School Case 302-005, July 2001. (Revised March 2020.)
- November 2009 (Revised January 2011)
- Case
International AIDS Vaccine Initiative
By: Allen S. Grossman and Cathy Ross
Dedicated to accelerating the development of a safe, effective, accessible, preventive HIV vaccine, the International AIDS Vaccine Initiative (IAVI) pioneered ways of addressing the inadequate incentive structures that prevented progress toward vaccines for AIDS and... View Details
Keywords: Developing Countries and Economies; Globalized Firms and Management; Health Care and Treatment; Health Disorders; Business and Government Relations; Partners and Partnerships; Research and Development; Social Enterprise; Health Industry
Grossman, Allen S., and Cathy Ross. "International AIDS Vaccine Initiative." Harvard Business School Case 310-015, November 2009. (Revised January 2011.)